Peptides · Peptide comparison
Acetyl Hexapeptide-3 (Argireline) vs Palmitoyl Tetrapeptide-7
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
Anti-inflammatory matrikine peptide that reduces IL-6-driven inflammaging for calmer, more youthful skin.
- Cosmetic
- Cosmetic
At a glance
Quick comparison
Efficacy
Benefit ratings
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Anti-Inflammatory
Anti-Aging
Skin Barrier Support
Technical data
Compound specifications
Acetyl Hexapeptide-3 (Argireline)
- Molecular formula
- C35H62N14O11S
- Molecular weight
- 887.0 Da
- Half-life
- Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
- Bioavailability
- Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
- CAS number
- 616204-22-9
Palmitoyl Tetrapeptide-7
- Molecular formula
- C34H62N8O7
- Molecular weight
- 694.9 Da
- Half-life
- Susceptible to enzymatic degradation; palmitoyl anchor reduces proteolytic cleavage rate compared to unmodified peptide
- Bioavailability
- Enhanced topical penetration via palmitoyl lipid modification enabling membrane interaction and dermal delivery
- CAS number
- 221227-05-0
Protocols
Dosing compared
Acetyl Hexapeptide-3 (Argireline)
Topical
- 5-10% concentration (cream or serum)Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effectUsed as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]
Palmitoyl Tetrapeptide-7
Topical
- Under 10 ppm (<0.001%) in finished productOnce or twice daily · OngoingCustomary leave-on cosmetic use is below 10 ppm of the active peptide [6]. Pal-GQPR is almost always used as a co-active alongside Pal-GHK in the Matrixyl 3000 blend rather than on its own.
- ~3% trade solution (Matrixyl 3000 blend)Twice daily · ~2 monthsIn manufacturer clinical testing the trade-solution blend was applied twice daily for about two months [6]. The ~3% figure refers to the diluted trade solution, which contains only ppm-level active peptide.
Applications
Best suited for
Acetyl Hexapeptide-3 (Argireline)
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][4].
- Those with needle phobia who want botulinum toxin-like effects without injections
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4].
- People targeting crow's feet, forehead lines, and glabellar creases
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Palmitoyl Tetrapeptide-7
- Individuals with aging skin showing signs of chronic low-grade inflammation
- Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with aging skin showing signs of chronic low-grade inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Those seeking to reduce UV-damage-related skin aging (photoaging)
- Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on those seeking to reduce uv-damage-related skin aging (photoaging). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- People looking for synergistic peptide therapy in Matrixyl 3000 products
- Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on people looking for synergistic peptide therapy in matrixyl 3000 products. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
- Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Palmitoyl Tetrapeptide-7
Common
- Mild Redness
- Slight Tingling
- Mild Irritation with Other Actives
- Dryness
Uncommon
- Allergic Contact Dermatitis
Serious
- Paradoxical Inflammatory Response
Research status
Safety & evidence
Acetyl Hexapeptide-3 (Argireline)
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. In cell-culture testing, significant cytotoxicity appeared only at concentrations 18 to 10,000 times higher than the reference drug doxorubicin [5]. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- Known hypersensitivity to acetyl hexapeptide-3 or formulation components
- Active skin infections or open wounds at the application site
- No known systemic contraindications at cosmetic concentrations
- Use with caution in individuals with neuromuscular disorders (theoretical concern)
Palmitoyl Tetrapeptide-7
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Palmitoyl tetrapeptide-7 (Eyeliss) shows excellent safety for periocular use with minimal irritation potential (Draize score <0.5 at 2% concentration). No serious adverse events in cosmetic formulations used for 15+ years. Eye irritation testing per OECD 404 confirms safety; no systemic toxicity in repeat-dose oral studies. Mild local effects limited to topical application site with no dermal penetration.
Contraindications
- Known hypersensitivity to palmitoyl tetrapeptide-7 or formulation excipients
- Active skin infections at the application site
- Severely compromised skin barrier with active inflammation requiring medical intervention
- No known systemic contraindications at cosmetic concentrations
Decision guide
Which is right for you?
Acetyl Hexapeptide-3 (Argireline)
Choose Acetyl Hexapeptide-3 (Argireline) if…
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Palmitoyl Tetrapeptide-7
Choose Palmitoyl Tetrapeptide-7 if…
- Individuals with aging skin showing signs of chronic low-grade inflammation
- Those seeking to reduce UV-damage-related skin aging (photoaging)
- People looking for synergistic peptide therapy in Matrixyl 3000 products
- Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides